Ofi Invest Asset Management »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ofi Invest Asset Management

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Ofi Invest Asset Management from 13F filings

Historical chart of Ofi Invest Asset Management investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Ofi Invest Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Ofi Invest Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.2M 4.9M 1.88
2023-09-30 $4.1M 4.4k 938.72

More positions owned by Ofi Invest Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Amazon (AMZN)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Merck & Co (MRK)
Caterpillar (CAT)
salesforce (CRM)
Oracle Corporation (ORCL)
Eli Lilly & Co. (LLY)
BlackRock (BLK)
Pepsi (PEP)
UnitedHealth (UNH)

View all positions for Ofi Invest Asset Management

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&g Investment Management
M&G
Calamos Advisors
Wolverine Asset Management
MacKay Shields
Polar Securities
CNH Partners
Millennium Management
Absolute Investment Advisers
Citadel Advisors
Kohlberg Kravis Roberts & Co
SSI Investment Management
Morgan Stanley
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Amundi

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1